Skip to main content

Table 1 Description of the study population

From: Gender disparities in diabetes and coronary heart disease medication among patients with type 2 diabetes: results from the DIANA study

 

Men

Women

p-value

 

(n = 624)

(n = 522)

 

Variables of interest

n

%

n

%

 

Age in years (mean, SD*)

67.2 (10.1)

69.7 (10.5)

 

Age in years

     

 ≤59

137

22.0

84

16.1

 

 60 - 69

193

30.9

129

24.7

 

 70 - 79

239

38.3

231

44.3

 

 ≥80

55

8.8

78

14.9

0.0001

Years of school education

     

 ≤9

433

70.9

395

76.9

 

 10 - 12

104

17.0

94

18.2

 

 ≥13

74

12.1

25

4.9

0.0001

Marital status

     

 Single/ widowed/ divorced

112

18.1

209

40.2

 

 Married

508

81.9

311

59.8

<0.0001

Occupational status

     

 Employed

158

26.5

78

15.7

 

 Retired

403

67.5

318

63.9

 

 Housewife

0

0

80

16.1

 

 Other

36

6.0

22

4.4

<0.0001

Smoking history

     

 Never

174

28.0

375

72.0

 

 Ex-smoker

355

57.2

100

19.2

 

 Current smoker

92

14.8

46

8.8

<0.0001

Alcohol consumption

     

 Abstainer

139

22.3

283

54.2

<0.0001

Body mass index (kg/m²)

     

 <25

76

12.2

78

14.9

 

 25 - <30

255

40.9

187

35.8

 

 30 - <35

194

31.1

161

30.8

 

 ≥35

98

15.8

96

18.4

0.19

Glycemic control by HbA 1c

     

 Good (≤6.4%)

241

38.6

213

41.1

 

 Moderate (6.5 - 7.4%)

239

38.3

212

40.9

 

 Poor (≥7.5%)

144

23.1

93

18.0

0.10

Mean HbA 1c (SD) in %

6.9 (1.1)

6.8 (1.0)

0.14

Mean HDL (SD) in mg/dl

47.7 (14.3)

57.3 (17.2)

<0.0001

Mean systolic BP (SD) in mmHg

137.8 (18.1)

136.8 (19.0)

0.41

Mean diastolic BP (SD) in mmHg

79.4 (10.2)

79.6 (10.5)

0.68

Physician reported time since diabetes diagnosis

 ≤5 years

241

38.6

213

40.8

 

 6 – 10 years

185

29.7

146

28.0

 

 11 – 15 years

104

16.7

81

15.5

 

 ≥16 years

94

15.1

82

15.7

0.82

Appointments with GPs (last 3 months)

     

 ≤1

260

41.7

197

37.9

 

 2 – 3

245

39.3

216

41.5

 

 ≥4

119

19.1

107

20.6

0.43

Participation in a DMP-DM

471

79.4

398

81.7

0.34

Medication adherence

     

 Good

455

75.6

385

77.0

 

 Moderate

132

21.9

102

20.4

 

 Poor

15

2.5

13

2.6

0.83

General health status (self-rated)

     

 Excellent or very good

62

10.0

40

7.7

 

 Good

366

58.7

291

55.8

 

 Fair

174

27.9

172

32.9

 

 Poor

21

3.4

19

3.6

0.21

Physician diagnosed comorbidities

     

 Hypertension

488

78.3

407

78.1

0.93

 Hypercholesterolemia

350

56.2

300

57.8

0.58

 Coronary heart disease

147

23.6

67

12.8

<0.0001

 Heart failure

75

12.0

64

12.3

0.89

 Intermittent claudication

96

15.4

36

6.9

<0.0001

 Stroke

47

7.5

22

4.2

0.02

 Nephropathy

76

12.2

45

8.6

0.05

 Retinopathy

51

8.2

35

6.7

0.35

 Neuropathy

144

23.1

104

20.0

0.20

 Depression

67

10.7

97

18.6

0.0002

 Cancer

63

10.1

49

9.4

0.70

  1. *SD = standard deviation; HbA1c = glycated haemoglobin A1c; GP = general practitioner;
  2. DMP-DM = disease management program for treatment of patients with type 2 diabetes.
  3. Missing values: education: 21, marital status: 6, occupational status: 51, smoking: 4, BMI: 1, HbA1c: 4, HDL: 270, systolic and diastolic BP: 70, appointments with GPs: 2, DMP-DM: 66, adherence: 44, health status: 1, hypertension: 2, hypercholesterolemia: 4, CHD: 2, heart failure: 1, intermittent claudication: 1, stroke: 2, nephropathy: 1, retinopathy: 1, depression: 1, cancer: 1
  4. Significant results (p < 0.05) by χ² test are printed bold.